Skip to content

AVALO THERAPEUTICS, INC.: 10-K filed 2018-04-02

What AVALO THERAPEUTICS, INC. reported in its annual report filed 2018-04-02 (fiscal FY 2017): 48 published measures, 154 facts as tagged in accession 0001628280-18-003890.

This filing

Form
10-K (annual report)
Filed
2018-04-02
Fiscal period
fiscal FY 2017
Accession
0001628280-18-003890 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All AVALO THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-12-3143,124,094USD
At 2016-12-315,768,865USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2017-12-3115,264,486USD
At 2016-12-315,561,863USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2017-12-3127,859,608USD
At 2016-12-31207,002USD
At 2015-12-3113,083,727USD
At 2014-12-31-26,330,664USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2017-12-312,472,187USD
At 2016-12-315,127,958USD
At 2015-12-3121,161,967USD
At 2014-12-3111,742,349USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-10-01 to 2017-12-31-3,091,000USD92
2017-01-01 to 2017-12-3111,869,823USD365
2017-07-01 to 2017-09-3018,721,000USD92
2017-04-01 to 2017-06-30-1,799,000USD91
2017-01-01 to 2017-03-31-1,961,000USD90
2016-10-01 to 2016-12-31-1,639,000USD92
2016-01-01 to 2016-12-31-16,471,603USD366
2016-07-01 to 2016-09-30-6,169,000USD92
2016-04-01 to 2016-06-30-3,524,000USD91
2016-01-01 to 2016-03-31-5,140,000USD91
2015-01-01 to 2015-12-31-10,490,103USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2017-01-01 to 2017-12-3112,519,405USD365
2016-01-01 to 2016-12-31-14,573,138USD366
2015-01-01 to 2015-12-31-10,163,380USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2017-01-01 to 2017-12-3123,325USD365
2016-01-01 to 2016-12-3134,883USD366
2015-01-01 to 2015-12-3119,984USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2017-01-01 to 2017-12-3127,813,137USD365
2016-01-01 to 2016-12-311,152,987USD366
2015-01-01 to 2015-12-310USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2017-01-01 to 2017-12-313,737,081USD365
2016-01-01 to 2016-12-31-1,425,988USD366
2015-01-01 to 2015-12-3119,602,982USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2017-01-01 to 2017-12-31-18,912,257USD365
2016-01-01 to 2016-12-31-34,883USD366
2015-01-01 to 2015-12-31-19,984USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-12-31-58,165,260USD
At 2016-12-31-70,035,083USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2017-01-01 to 2017-12-3118,410,005shares365
2016-01-01 to 2016-12-318,830,396shares366
2015-01-01 to 2015-12-312,226,023shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2017-01-01 to 2017-12-3118,754,799shares365
2016-01-01 to 2016-12-318,830,396shares366
2015-01-01 to 2015-12-312,226,023shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2017-10-01 to 2017-12-31-0.11USD/shares92
2017-01-01 to 2017-12-310.42USD/shares365
2017-07-01 to 2017-09-300.52USD/shares92
2017-04-01 to 2017-06-30-0.14USD/shares91
2017-01-01 to 2017-03-31-0.19USD/shares90
2016-01-01 to 2016-12-31-1.87USD/shares366
2015-01-01 to 2015-12-31-4.71USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2017-10-01 to 2017-12-31-0.11USD/shares92
2017-01-01 to 2017-12-310.42USD/shares365
2017-07-01 to 2017-09-300.52USD/shares92
2017-04-01 to 2017-06-30-0.14USD/shares91
2017-01-01 to 2017-03-31-0.19USD/shares90
2016-01-01 to 2016-12-31-1.87USD/shares366
2015-01-01 to 2015-12-31-4.71USD/shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2017-01-01 to 2017-12-311,966,519USD365
2016-01-01 to 2016-12-310USD366
2015-01-01 to 2015-12-310USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2017-12-3144,612USD
At 2016-12-3143,243USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2017-01-01 to 2017-12-311,157,252USD365
2016-01-01 to 2016-12-311,694,891USD366
2015-01-01 to 2015-12-31394,748USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-12-3113,889,982USD365
2016-01-01 to 2016-12-31-16,080,047USD366
2015-01-01 to 2015-12-31-11,009,947USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2017-12-3110,991,367USD
At 2016-12-315,662,794USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2017-12-3111,406,437USD
At 2016-12-314,311,863USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2017-12-311,298,980USD
At 2016-12-311,010,209USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2017-12-3114,292,282USD
At 2016-12-310USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2017-12-3117,664,480USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-01-01 to 2017-12-3113,923,155USD365
2016-01-01 to 2016-12-3117,233,034USD366
2015-01-01 to 2015-12-3111,009,947USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2017-12-31382,153USD
At 2016-12-310USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2017-10-01 to 2017-12-311,961,000USD92
2017-01-01 to 2017-12-314,372,578USD365
2017-07-01 to 2017-09-30965,000USD92
2017-04-01 to 2017-06-30494,000USD91
2017-01-01 to 2017-03-31953,000USD90
2016-10-01 to 2016-12-31773,000USD92
2016-01-01 to 2016-12-3110,149,879USD366
2016-07-01 to 2016-09-304,582,000USD92
2016-04-01 to 2016-06-302,502,000USD91
2016-01-01 to 2016-03-312,293,000USD91
2015-01-01 to 2015-12-316,587,183USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-12-3131,266,989shares
At 2016-12-319,434,141shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2017-12-3183,338,136USD
At 2016-12-3170,232,651USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2017-12-31154,259USD
At 2016-12-31130,934USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2017-12-31109,647USD
At 2016-12-3187,691USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2017-12-3117,664,480USD
At 2016-12-310USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2017-12-3124,272USD
At 2016-12-310USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2017-12-31703,225USD
At 2016-12-31391,253USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2016-12-310USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

PeriodValueUnitDays
At 2017-12-317,144USD
At 2016-12-310USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2017-01-01 to 2017-12-317,772,084USD365
2016-01-01 to 2016-12-31-16,471,603USD366
2015-01-01 to 2015-12-31-10,490,103USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2017-10-01 to 2017-12-313,021,000USD92
2017-01-01 to 2017-12-317,941,584USD365
2017-07-01 to 2017-09-302,152,000USD92
2017-04-01 to 2017-06-301,439,000USD91
2017-01-01 to 2017-03-311,330,000USD90
2016-10-01 to 2016-12-311,095,000USD92
2016-01-01 to 2016-12-317,083,155USD366
2016-07-01 to 2016-09-301,703,000USD92
2016-04-01 to 2016-06-301,636,000USD91
2016-01-01 to 2016-03-312,649,000USD91
2015-01-01 to 2015-12-314,422,764USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2017-01-01 to 2017-12-3121,956USD365
2016-01-01 to 2016-12-3126,856USD366

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2017-01-01 to 2017-12-31425,476USD365
2016-01-01 to 2016-12-3126,856USD366
2015-01-01 to 2015-12-3123,508USD365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2017-01-01 to 2017-12-31403,520USD365
2016-01-01 to 2016-12-310USD366

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2017-01-01 to 2017-12-31-53,640USD365
2016-01-01 to 2016-12-31-391,556USD366
2015-01-01 to 2015-12-31519,844USD365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2017-01-01 to 2017-12-312,799,148USD365
2016-01-01 to 2016-12-310USD366
2015-01-01 to 2015-12-310USD365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2017-01-01 to 2017-12-31-832,629USD365
2016-01-01 to 2016-12-310USD366
2015-01-01 to 2015-12-310USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2017-01-01 to 2017-12-311,693,498USD365
2016-01-01 to 2016-12-312,003,182USD366

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-12-31247,195USD365
2016-01-01 to 2016-12-31132,472USD366
2015-01-01 to 2015-12-310USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-12-31202,622USD365
2016-01-01 to 2016-12-310USD366
2015-01-01 to 2015-12-310USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-12-3196,065USD365
2016-01-01 to 2016-12-31332,100USD366
2015-01-01 to 2015-12-31-268,709USD365

Inspect the source

Entity
AVALO THERAPEUTICS, INC. / CIK 0001534120
Captured
2026-09-20T09:16:35.394Z
SEC response SHA-256
c27cef5388033067af62e0489a1b2af90f086713b680df0f63e0f63ad2ea1ca3

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001534120.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))